| J1602 | Injection, golimumab, 1 mg, for intravenous use | 45,200 | $10 | $497.2K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,750 | $30 | $365.5K |
| J3262 | Injection, tocilizumab, 1 mg | 73,180 | $1 | $292.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 8,100 | $30 | $210.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $80 | $43.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 350 | $120 | $41.5K |
| J0897 | Injection, denosumab, 1 mg | 1,920 | $20 | $34.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $80 | $25.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 420 | $40 | $17.9K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 250 | $20 | $4.4K |